Over the past decade, CRISPR has reshaped how researchers think about viral vector engineering. The shift isn't just about speed—though CRISPR-mediated viral vector construction is undeniably faster than traditional cloning—it's about the kinds of experiments that now feel possible. Tasks that once required long cloning cycles or careful recombination strategies can be...
In the field of molecular biology, the ability to introduce exogenous genetic material into specific cell types is a fundamental requirement for functional genomics and biochemical analysis. While traditional chemical transfection methods often fall short in primary cells or complex in vivo models, recombinant viral vectors have emerged as the gold standard for high-efficiency gene...
Flow cytometry has long been celebrated for its ability to turn complex cellular systems into quantifiable, high‑resolution data. But as the field pushes toward higher throughput, more physiologically relevant assays, and increasingly integrated workflows, researchers are beginning to look beyond the cytometer itself. One of the most interesting developments happening in parallel is the rapid...
The transition from bulk "macro-scale" processing to precision "micro-scale" manipulation has fundamentally altered the trajectory of modern biotechnology. At the forefront of this shift lies microfluidic encapsulation—a technology that allows for the discrete packaging of biological entities within picoliter-sized droplets or solid matrices. As we move further into the decade,...
Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs.
Functional Target Screening: Moving Beyond Binding
Traditional phage display often...
As biopharmaceutical pipelines expand and therapeutic modalities grow more complex, the demand for highly specific, reproducible, and customizable antibodies has never been greater. Two categories—post‑translational modification (PTM)–specific antibodies and anti‑idiotype (anti‑ID) antibodies—have become essential tools for both discovery research and regulated bioanalytical...
In vitro neuroscience is undergoing a notable transition as researchers push for models that better reflect human neuronal function. Traditional biochemical and imaging assays remain essential, but they often lack the ability to capture network‑level dynamics—one of the most persistent pain points in CNS research. This gap has contributed to the growing adoption of microelectrode...
The development of therapeutics for central nervous system (CNS) disorders, particularly neurodegenerative conditions like Alzheimer's disease, presents some of the highest attrition rates in the pharmaceutical sector. For decades, drug developers have hit a major industry pain point: the translational gap. Traditional preclinical pipelines rely heavily on two-dimensional (2D) cell cultures and...
Advanced liposome strategies, including PG anionic formulations and microfluidic manufacturing, are driving a paradigm shift in pharmaceutical development by resolving structural stability and drug compatibility challenges for complex therapeutics.
Industrial Trends in Lipid-Based Drug Delivery
The field of nanomedicine is experiencing a major industrial transformation, largely...
RNA therapeutics face key delivery challenges including instability, targeting limits, and scale-up variability. Advances in lipid nanoparticles, micelles, and integrated platforms—such as those developed by Creative Biolabs—are improving translational success.
Lipid-based drug delivery systems are central to modern RNA therapeutics, gene editing technologies, and...
Induced pluripotent stem cells (iPSCs) have deeply affected biomedical research by offering a renewable source of patient‑specific cells. Their ability to differentiate into virtually any cell type makes them a cornerstone of regenerative medicine, disease modeling, and drug discovery. Over the past decade, the field has accelerated, with researchers worldwide exploring how iPSCs can be...
Over the past decade, induced pluripotent stem cells (iPSCs) have reshaped the landscape of biological research. What began as a breakthrough in cellular reprogramming has evolved into a powerful platform for exploring human development, modeling disease mechanisms, and dissecting the genetic foundations of cellular behavior. Today, the combination of precise genome editing and directed...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
